Tuesday, January 10, 2017 8:00AM - 4:00PM PST Genentech Campus 1 DNA Way South San Francisco, CA 94080

Breakthroughs in Healthcare Diversity Symposium Creating Patient, Clinician, & Technology Networks

Presented By

The Breakthroughs in Healthcare Diversity Symposium:

Creating Patient, Clinician, & Technology Networks is an

educational symposium focusing specifically on the

development of a collaborative diversity and inclusion

healthcare network to solve the challenges surrounding the

delivery of quality healthcare to underserved and vulnerable

patient groups. The goal of establishing this network is to

connect patients, clinicians, researchers, and industry

professionals who are passionate about diversity and inclusion

and serving underserved patient populations, specifically racial

and ethnic minorities, women, lesbian, gay, bisexual,

transgender (LGBT) persons, and vulnerable patient

populations of lower socioeconomic status. The educational

symposium focuses specifically on the latest trends, challenges,

opportunities, and best practices of implementing strategies

and tactics to make healthcare and the life sciences more

diverse and inclusive, as well as understand how to better serve

diverse patient groups. Attendees will learn the newest insights

and ideas, discuss practical solutions, and meet new industry

and marketplace colleagues. The symposium, which takes place

in San Francisco on 1/10/17, will feature keynote speakers,

educational panel discussions, breakout sessions, and

networking.

Introduction

2014 U.S. Clinical

Trial Participants From 2014 U.S. Census American Community Survey

Caucasian/

White

89%

African-

American

5%

Asian

5%

Hispanic

1%

What percentage of racial backgrounds

comprise U.S. clinical trial participants?

Email info@chisite.org to register

How Diverse and Inclusive are

Executive leader positions in the U.S.?

Dear Healthcare Professionals, Clinicians, Technologists, and Patients,

As the President of Center for Healthcare Innovation and a health

sector teacher, researcher, and scholar, I invite you to the

“Breakthroughs in Healthcare Diversity Symposium: Creating Patient,

Clinician, & Technology Networks”. Over the last six years, we have led

a similar symposium in Chicago, our Diversity, Inclusion, & Life

Sciences Symposium, and we have learned that the health sector still

faces major diversity and inclusion challenges. Some of the figures and

statistics shown here are alarming, and they indicate just how much

progress our industry must make to serve diverse patient groups and

reflect that diversity within our organizations.

The “Breakthroughs in Healthcare Diversity Symposium”, along with

CHI’s other healthcare diversity educational programs, aims to be the

leading annual, collaborative symposium for health sector

professionals, patients, clinicians, technologists, entrepreneurs, patient

advocates, policymakers, researchers, scientists, academics, and service

providers to discuss diversity and inclusion in the health sector. The

symposium focuses specifically on the latest trends, challenges,

opportunities, and best practices of implementing strategies and tactics

to make these industries more diverse and inclusive, as well as

understand how to better serve different patient groups. Attendees will

learn the newest insights and ideas, discuss practical solutions, and

meet industry and marketplace colleagues. We invite you to explore our

site and contact us with any questions or thoughts.

Please visit chisite.org. for more information. We hope to see you in

San Francisco on January 10, 2017.

Warmest Regards,

Dr. James J. Gillespie, PhD, JD, MPA

President

Center for Healthcare Innovation

Introduction

4.2% Female

Among Fortune 500 CEOs

4% Non-White

Among Fortune 500 CEOs

Click Below to See Video of CHI’s

Other Diversity Symposium

JOIN a leading educational symposium on patient-centered

health outcomes and diversity in the treatment of diverse patient populations that include the LGBT community, women, racial and ethnic minorities, and individuals of low socioeconomic status

DISCUSS how diversity and inclusion drive innovation within

organizations

UNDERSTAND the obstacles to clinical trials, comparative

effectiveness research, and healthcare access for underrepresented patient populations

BUILD a collaborative network of patients, physicians,

technologists, researchers, and other healthcare stakeholders who have a passion for diversity and inclusion, in a manner that empowers patients in making healthcare decisions

ESTABLISH a workplace that embraces and promotes an

inclusive environment by leveraging the latest D&I trends and ideas

LEARN best practices for recruiting, retaining, and promoting a

diverse workforce, from entry-level to C-Suite and boardrooms

ACQUIRE new knowledge and ideas on the crucial role

technology plays in making healthcare more diverse and how technology firms are innovating healthcare delivery

FOCUS on building an organizational culture that attracts the

best and brightest people, resulting in a diverse workforce where all ideas are valued

NETWORK and share ideas with many of the country’s

leading life science and healthcare professionals who are passionate about diversity and inclusion

CREATE cross-sectorial and multi-industry collaboration and

innovation by connecting key partners in industry, patient groups, providers, and academia

Why Attend?

Agenda

Presented By Center for Healthcare Innovation CHI is an independent, 501(c)(3) research and educational institute that

helps patients and providers increase their knowledge and understanding of

the opportunities and challenges of maximizing healthcare value to improve

health and quality of life. We aim to make the world a healthier place. CHI

encourages and enables meaningful and executable innovation that aims to

address existing and ensuing healthcare dynamics through communication,

education, training, symposia, reports, and research.

National Biotechnology & Pharmaceutical Association NBPA is the world’s leading advocate, voice, and core connector for African-

Americans and Blacks in the life sciences industries, including the

biomedical, biotechnology, medical device, nanotechnology, and

pharmaceutical sectors. We are currently leading the first ever cross-

company survey of African- American life science professionals.

8:00AM Registration, Breakfast, & Networking

9:00AM Opening Remarks

9:15AM Distinguished Keynote Address

10:00AM Addressing Healthcare Disparities in Clinical Research & Comparative Effectiveness Research for Underserved Patient Groups Panel Discussion

11:30AM Chief Diversity Officers Roundtable

12:30PM Lunch

1:30PM What Role Does Technology Play in Healthcare Diversity? Panel Discussion

2:45PM 4th Panel Discussion: TBD

3:45PM Concluding Remarks

4:00PM Reception & Networking

Agenda

Addressing Healthcare Disparities in Clinical Research & Comparative Effectiveness

Research for Underserved Patient Groups Panel Discussion 2016 was the FDA’s “Year of Diversity in Clinical Trials.” According to the FDA, African-Americans represent 12 % of

the U.S. population but only 5% of clinical trial participants. Additionally, Hispanics represent 18% of the U.S.

population but only 1% percent of clinical trial participants. In a country where minorities are estimated to

outnumber white Americans by 2044, the inclusion of individuals of varied races, ethnicities, ages, gender, and sexual

orientations in clinical research can help prevent disparities in the evaluation of potential new medicines.

Historically, racial and ethnic minorities, women, the elderly, and the LGBT community have been underrepresented

in clinical trials and comparative effectiveness research (CER). Clinical research provides crucial information on

whether new drugs and treatments are safe and effective, and it is vital for researchers and the entire health sector to

ensure that research participants are representative of the larger U.S. population. Additionally, as newer concepts

such as precision medicine and biomarkers move to the forefront of modern medicine, diversity in clinical research

will have even greater implications. This panel brings together a leading group of researchers, patients, and clinical

trial experts to discuss the obstacles to clinical trials, as well as how to make the clinical research ecosystem as diverse

and inclusive as possible.

Chief Diversity Officers Roundtable According to a recent report, there are only five African-American CEOs at the nation's 500 largest companies. And a

Forbes report last year indicated that 28% of Fortune 500 firms list just one female director, despite that studies have

shown that it takes at least three female board members to achieve a critical mass for enhancing governance and

performance. Moreover, a recent Harvard Business Review article reports that without diversity in organizational

leadership, women are 20% less likely than white men to win endorsement for their ideas, people of color are 24%

less likely, and the LGBT community is 21% less likely, all of which stifle the creative and innovative process. Given

the rapidly shifting U.S. demographic trends among U.S. patients, it is more important than ever for healthcare

organizations to reflect diversity and inclusion within the organization. Attracting and recruiting the best and

brightest diverse talent can help organizations drive innovation and new thinking. However, many organizations face

a myriad of challenges when attempting to achieve a desired level of diversity within their organizations. This panel

features a group of Chief Diversity Officers and senior executives who will discuss the challenges, opportunities, and

best practices of attracting, retaining, and promoting minorities, women, and other underrepresented human talent,

as well as how their organizations are adapting to shifting demographics among U.S. patients.

What Role Does Technology Play in Healthcare Diversity? Panel Discussion The first two panels explore and highlight some of the diversity and inclusion challenges facing health sector

organizations as they attempt to better serve diverse patient groups as well as create diverse and inclusive cultures

within these organizations. Additionally, technological advances are dramatically transforming healthcare and the

way that care is delivered. A recent PwC Health Research Institute Analysis highlights this shift toward technology:

32% of consumers now have at least one health app on their mobile device, up from just 16% in 2013, and there are

now over 165,000 health-related apps available for mobile devices. Moreover, 72% of consumers age 18-44 prefer to

use telehealth services, such as video conferencing, to consult with a mental health provider rather than a traditional

in-person visits. Health sector organizations are leveraging the power of data analytics to determine patterns and

make smarter, more informed decisions in a timelier manner. This panel will bring together leading healthcare and

technology experts, futurists, and data professionals to explore how healthcare and technology companies can use

technology to make health sector organizations more diverse, help these organizations better serve diverse patient

groups, and utilize the intersection of technology and healthcare to establish patient-powered networks.

4th Panel Discussion TBD

Distinguished Speakers

Mr. Marlon Doles is the Associate Director,

Learning & Development - Inclusion & Diversity of

Gilead Sciences. Marlon is a Human Resources

professional with experience in Inclusion &

Diversity, Talent Management, Talent Acquisition,

Diversity Recruitment and Outreach, and Learning &

Development. He also have extensive experience as a Professional

Coach and have both a APECS and Psychosynthesis certifications. His

prior roles include Global Talent Acquisition Leader, Inclusion and

Diversity at GSK, Diversity Recruiting Programs Lead at Merck, and

Director, Executive Staffing & Diversity at Wyeth Pharmaceuticals.

Marlon holds a BA in Advertising/Public Relations from University of

South Carolina-Columbia.

Dr. Tri Do, MD, MPH, is the Chief Medical

Officer of the A&PI Wellness Center, a health

center in San Francisco that provides medical, social

and behavioral health services. It also serves as focal

point for community organizing for LGBT people,

racial and ethnic minorities, immigrants, low-income

persons, and the homeless. As an assistant professor at the

University of California, San Francisco and a researcher with the

Global Forum on MSM and HIV, Dr Do’s research focuses on the

social epidemiology of health disparities in LGBT populations. Dr Do

has also provided HIV medical support, guideline development, and

clinical training through the Centers for Disease Control and

Prevention. He is also global head of clinical research at Roche

Molecular Diagnostics.

Mr. James Bouquin is the CEO of the Cancer

Support Community San Francisco Bay Area, leading

his team to provide a wide range of free services to

about 2,000 cancer patients and their families in the

Bay Area each year. It is the only organization of its

kind in Northern California. The mission of the

Cancer Support Community is to ensure that all people impacted by

cancer are empowered by knowledge, strengthened by action, and

sustained by community. Prior to his current role, James served as

the President at Arthritis Foundation, Northern California Chapter.

James holds a BA with Distinction in Human Biology from Stanford

University. His areas of expertise include non-profits, community

outreach, and program development.

Rhonda Collins, MSN, RN, is the Chief Nursing

Officer of Vocera, where she is responsible for

working with nursing leaders around the world to

increase their understanding of the company’s

communication solutions and share clinical best

practices and to improve care team workflow and

patient care. A registered nurse for 28 years, Rhonda holds a

master’s degree in science nursing administration from the University

of Texas. After 10 years delivering direct patient care, Rhonda held

several leadership positions in hospitals across Texas before entering

the healthcare technology industry. As the inspiration for

the American Nurse Project, a thought leader and innovator, Rhonda

is a frequent speaker on the evolving role of nurses, the importance

of communication, and how to use technology to improve care team

collaboration and satisfaction.

Dr. Laura Castillo-Page, PhD, is the Acting

Chief Diversity and Inclusion Officer of the

Association of American Medical Colleges (AAMC).

As acting chief diversity and inclusion officer, Laura

Castillo-Page, PhD, provides strategic vision and

leadership for the AAMC’s diversity and inclusion

activities across the medical education community, and leads the

association’s Diversity Policy and Programs unit. Previously, Dr.

Castillo-Page served as senior director of diversity policy and

programs and organizational capacity building at the AAMC, and was

responsible for strategic planning, operations management, and staff

development. She also led the organization capacity building portfolio

of work to promote diversity and inclusion across the continuum of

academic medicine. Dr. Castillo-Page received her BA from Fordham

University, and earned an MA in political science, an MS, and PhD in

educational administration and policy studies from the University at

Albany, SUNY.

Dr. Sergio Aguilar-Gaxiola, MD, PhD, is a Professor of Internal Medicine, School of Medicine, University of California, Davis. He is the Founding Director of the Center for Reducing Health Disparities at the UC Davis Health System. Dr. Aguilar-Gaxiola, formerly a faculty member at California State University, Fresno, has been actively

involved in a collaborative program designed to increase access to mental health services among the Central Valley's low-income, underserved, rural populations. Dr. Aguilar-Gaxiola also holds several World Health Organization advisory positions and is the coordinator for Latin America and the Caribbean of the WHO World Mental Health initiative. He is also a member of the board of trustees of the American Society of Hispanic Psychiatry. His research includes cross-national studies on patterns of psychiatric disorders in general population samples, and the development of culturally sensitive psychiatric diagnostic instruments. His most recent projects include translating mental health research into practical information for consumers (and their families), health professionals, and policy makers. Aguilar-Gaxiola received his medical degree at the Autonomous University of Guadalajara in Mexico and his Ph.D. in clinical-community psychology at Vanderbilt University.

Dr. Owen Garrick, MD, MBA, is President &

COO of Bridge Clinical Research. Bridge Clinical

Research is a global patient recruitment healthcare

communications company. It is also the leading

company focused on increasing the participation of

minority investigators and patients in clinical trials.

Dr. Garrick was formerly Director of Corporate Strategy and M&A

at McKesson. Prior to McKesson, Dr. Garrick was Global Head of

M&A Negotiations at Novartis. Previously he was at Goldman Sachs

in New York. Dr. Garrick earned his MD from Yale, MBA from

Wharton. He holds an AB from Princeton University. Dr. Garrick

also serves on the boards of Sutter Health, the American Psychiatric

Association Foundation and Samuel Merritt University. He was

confirmed to the HHS Secretary’s Advisory Committee on Human

Research Protections in 2012.

Mr. Joseph Gaspero is the President & Co-

Founder of the Center for Healthcare Innovation, a

non-profit research and educational institute for

healthcare. Mr. Gaspero is responsible for all daily

operations of CHI. He is a veteran of the U.S.

military and has extensive experience in the non-

profit sector. He has led the Diversity, Inclusion, & Life Sciences

Symposium since 2011. Mr. Gaspero is passionate about disparities in

clinical trials and healthcare. He has researched disparities in clinical

trials, patient-driven healthcare value and innovation, and drug pricing

complexities. He also leads CHI’s educational initiatives across the

country, including healthcare innovation workshops in Washington

DC and a Healthcare CEO Roundtable in Manhattan. Joseph has also

led other research exploring drug pricing debates, healthcare

legislation, and pharmaceutical-ACO collaboration.

Distinguished Speakers

Dr. James J. Gillespie, PhD, JD, MPA, is the CEO of the Center for Healthcare Innovation. He is a teacher, researcher, and scholar, with expertise focusing on the management, strategy, and operations of the healthcare sector. Dr. Gillespie is President of the Center for Healthcare Research. His research has appeared in Academy of

Management Review, American Behavioral Scientist, European Journal of Social Psychology, Federal Reserve Bank, Harvard Business Review, and Strategic Management Journal. His current research analyzes innovative strategic partnerships among large healthcare and life science organizations. Dr. Gillespie also has extensive experience in curriculum design and online learning. He has previously taught at Illinois Institute of Technology, Northwestern University, University of Illinois, and University of Wisconsin. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; and Carnegie Mellon University.

Ms. Regina Greer-Smith, MPH, is a member of

the Advisory Panel for Patient Engagement at the

Patient Centered Outcomes Research Institute

(PCORI). Regina is the President and Owner of

Healthcare Research Associates, LLC. Regina’s work

includes building and maintaining collaborations

between communities and stakeholders that enable improved

healthcare outcomes. Regina is a consultant /healthcare coordinator

to agencies providing services to developmentally and intellectually

disabled adults in Illinois and the use of mobile technology to enable

collaboration between patients/caregivers and providers. She is the

developer and principal investigator of The S.T.A.R. Initiative. The

mission of The S.T.A.R. Initiative is to increase minority participation

in patient-centered outcomes research and clinical trials. Regina

holds a Master of Public Health Degree (MPH) from Benedictine

University and is a Fellow with The American College of Healthcare

Executives.

Dr. LaMisha Hill, PhD, is the Director of the Multicultural Resource Center at the Office of Diversity and Outreach at the University of California, San Francisco. Prior to her current role, Dr. Hill completed a Post-Doctoral Fellowship at UC Berkeley's Counseling & Psychological Services, and a Pre-Doctoral Internship at UC Riverside's

Counseling Center. Graduate training in Counseling Psychology from the University of Oregon provided foundations in multicultural and ecological frameworks that further sustain her efforts in diversity and inclusion initiatives in higher education. Dr. Hill is passionate about social justice, advocacy, and equity. She oversees programmatic efforts within the Multicultural Resource Center, which focus on student engagement, campus communities of color, community building, and mentorship.

Ms. Kristi Ebong, MPH, MBA, is the Director of

Health Technology at Cedars-Sinai Health System.

She drives progress in digital health and innovation,

and is actively involved with the Techstars

Healthcare Accelerator in Partnership with Cedars-

Sinai. She is also the first female and youngest

professional to serve on the board of the Badger Entrepreneurship

Forum, a Cali-based group of UW-Madison alumni. Her previous

experience includes digital health innovation and health IT at Stanford

Health Care; strategy, content development, and market research for

Healthspottr's private network of thought leaders. Kristi holds an

MPH and MBA degree from the Johns Hopkins University, and a BA

in Global Security/International Studies and Political Science from

University of Wisconsin-Madison.

Distinguished Speakers

Dr. Shervin Majd, PhD, is the Director of Mobile Health programs at NantMobile. He leads mobile health programs responsible for solution strategy and market requirements of digital health/wellness/genomics domains to empower patients and consumers. Prior to joining Nantmobile, he was advising The Angles Forum (TAF) as Entrepreneur

in Residence to identify investment opportunities in connected health, wellness and wearables solutions. In parallel, he was working with several startups as advisor and consultant to strategize their investment rounds, fine-tune clinical pilots and optimize product roadmap/go to market strategy. Previously, Dr. Majd was working at Vodafone xone the global ventures and incubation office in the bay area and responsible for incubation of startups, product launch across several international markets and corporate investment in mobile health and wellness domains. Dr. Majd holds a Ph.D. degree in Biomedical Engineering from the University of Tennessee and completed his post-doctorate training at the University of Maryland.

Mr. Alan Nevel, MBA, is the Vice President of Global Diversity & Inclusion at Thermo Fisher Scientific. He is a senior executive who enables business leaders to leverage the power of diverse talent, backgrounds and experiences to drive speed, productivity, innovation and growth. As Vice President, Global Diversity & Inclusion for Thermo

Fisher Scientific, Alan’s primary focus is on driving global, corporate-wide diversity and inclusion initiatives associated with talent acquisition, employee engagement and development, and community philanthropic involvement. His management expertise includes driving the development and implementation of value-added, best-in-class human resources, organizational change management, leadership, and talent development programs. His prior role was Director, Diversity & Inclusion at LBrands. He received his MBA from Weatherhead School of Management at Case Western Reserve University.

Mr. Julius Pryor III helps companies leverage Diversity & Inclusion to accelerate innovation and drive business results. He’s held executive roles at Johnson & Johnson (J&J), Coca-Cola Enterprises (CCE), Russell Athletic, Abbott Labs and Takeda Pharmaceuticals. He was Vice President of Global Diversity at both J&J and at Coke. Most recently,

Julius served as Head of Innovation, Diversity & Inclusion at biotech leader Genentech. Julius combines a unique vision for the future of D&I, a strong grounding in sales and management, and insights into what works across different industries and sectors. Julius saw the power of diversity to accomplish results during his 26 years of service in the U.S. Navy. He is a retired U.S. Navy Captain, Surface Warfare Officer and instructor for the Navy Officer Leadership Development Program. He’s held numerous Navy leadership roles including, Unit Commanding Officer and Fleet Staff Officer. He had the honor of serving on the re-commissioning crew of the historic USS Missouri (BB-63). Julius graduated from Morehouse College and The Williston Northampton School (Easthampton, MA). He sits on the boards of the Andrew Young Center for Global Leadership and the Center for Healthcare Innovation. He is a member of the Omega Psi Phi Fraternity, having pledged at the legendary Psi Chapter at Morehouse College.

Mr. Amri Johnson, MPH, is a writer, speaker, and organizational change and innovation scholar working with profit/non-profit companies to construct business solutions through understanding and making the most out of the wealth that difference provides, co-creating to optimize individuals and teams’ engagement and investment

in their work. Currently, as Head of Diversity and Inclusion with Novartis Institutes for BioMedical Research (NIBR), Johnson works with teams and their leadership to drive innovation through a focus on the sociology of drug discovery, helping to grow organizational talent capacity, and create an environment that thrives by inclusion. A graduate of Morehouse College he also holds a Master of Public Health (Epidemiology) from Rollins School of Public Health (Emory University). His current doctoral work is at Leiden University (The Netherlands) focusing on collaborative decision-making in organizations.

Dr. Mitesh B. Rao, MD, MHS, is the System Patient Safety Officer for Stanford Healthcare where he leads Patient Safety for the Enterprise. Dr. Rao also serves as Director of the Center for Advancing Patient Safety (CAPS), which focuses on advancing the science and implementing new innovations in the fields of Patient Safety and Quality Improvement. A

Board Certified Emergency Medicine Physician, he practices clinically as an Assistant Professor of Emergency Medicine at the Stanford School of Medicine. Dr. Rao also serves as a mentor to multiple healthcare-focused startups and accelerator groups across the country. Previously, he served as the Director of the Patient Safety Education Program at Northwestern Medicine, where he was helped implement systems-level improvements for quality and safety in institutions across the country and overseas. Dr. Rao was also the Head of Research and Integration for the health innovation program at Northwestern. In this role, he developed an expertise in improving care provision through innovative methodologies.

Dr. Michael Hogarth, MD, is a Professor of Internal Medicine and Pathology and Laboratory Medicine at UC Davis Medical Center. Michael Hogarth is a member of the Masters of Public Health faculty, the Medical Informatics graduate program faculty, and the UC Davis Computer Science graduate group. He also attends on the

Internal Medicine wards and serves in the Department of Pathology as a member of the Pathology Informatics faculty. He is the principal investigator for the California Electronic Death Registration System (CA-EDRS), the largest and most active electronic death certificate system in the U.S.. Michael Hogarth is a member of the American Medical Informatics Association (AMIA), Health Level 7 (HL-7), the National Association of Public Health Statistics and Information Systems (NAPHSIS), and the California Regional Health Information Organization (CalRHIO). Michael Hogarth holds a bachelor's degree in Biomedical Engineering from Texas A&M University and a Doctor of Medicine from University of Texas, Southwestern (Dallas, TX).

Distinguished Speakers

Mr. Marquise Stillwell, MBA, is the Founder and Principal of Openbox. As a business designer and developer for more than two decades, he grounds the Openbox vision in strategic planning from the fields of investing, product development, and technology. Marquise also works in creative leadership, teaching with the KaosPilots in Denmark

and South Africa to help students learn by doing. An active supporter of the arts, Marquise has collaborated with director Petter Ringbom on three short films and one feature-length movie, Shield and Spear (2014), about the rise of creative expression in post-apartheid South Africa. Marquise acts as a board member for the Lowline Underground Park and board advisor for the Andrew Goodman Foundation, and he is a mentor to Geeks Without Bounds and the Girls & Boys Club. He is also a supporter of the Joyce Theater,Makeshift magazine, and MCA Denver for their ability to inspire exploration and empower creative cultures. Marquise is passionate about the power of design, and has a boundless curiosity for life. You can find him riding his bike through the streets of Manhattan, doing his part to build a greener urban future.

Dr. Chad Womack, PhD, is the National Director of STEM Initiatives at the United Negro College Fund, including the UNCF-Merck Fellowship Program and the co-founder and co-lead of the White House-supported HBCU Innovation, Commercialization & Entrepreneurship. He co-founded The America21 Project and DC Innovates,

both innovation-based community and economic development nonprofit organizations dedicated to empowering metro-centers and underserved communities through STEM education, tech-entrepreneurship and access to capital. Dr. Womack also founded the Philadelphia Biotechnology & Life Sciences Institute as a nonprofit initiative dedicated to addressing unmet educational and workforce development needs of Philadelphia. He co-founded 3GEN Vaccines, a nano-biotechnology company. Prior to his entrepreneurial ventures, he completed research fellowships at the NIH, most recently at the National Institutes for Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and at the Harvard AIDS Institute at the Harvard School of Public Health and the Department of Immunology and Infectious Diseases.

Ms. Joanna Smith, MPH, is the CEO of Healthcare Liaison, Inc. She has 25 years experience in the fields of health, public health and mental health. She has worked as a medical social worker and hospital discharge planner in healthcare systems throughout the San Francisco Bay Area. Previous experience also includes work in home health and

community-based agencies. She has a thorough knowledge of both public and private sector healthcare systems and a special interest in cross-cultural issues in healthcare. Joanna received her Masters in Social Work from Tulane University in 1978 and her Masters in Public Health in Maternal and Child Health from the University of California, Berkeley in 1985. She is a licensed clinical social worker in the state of California - LCSW #9586. She also holds a credential as a member of the Academy of Certified Social Workers. Joanna is a member of the National Association of Social Workers, The Hastings Center, and is Founder of the National Association of Healthcare Advocacy Consultants.

Ms. Joanna Strober, is Co-founder and CEO of Kurbo Health, an app and personal coaching platform, based on Stanford Pediatric weight program, to help kids, teens and their families eat healthier and lose weight. Prior to founding Kurbo, Strober had 20 years of experience in direct private equity and venture capital investing, venture capital

fund of funds investing, business development, marketing and fundraising. Joanna has vast expertise marketing to women and families from two decades of advising and investing in successful consumer Internet companies such as BlueNile, Babycenter, eToys, Flycast, and Gloss.com. Joanna holds a bachelor’s degree in Political Science from the University of Pennsylvania and a JD from UCLA. Joanna is also the co-author of Getting to 50/50, a Random House book on women and leadership. As an experienced public speaker, she has given many talks on this topic TV, including the Today Show, and to corporations and educational institutions.

Dr. Arshya Vahabzadeh, MD, is the Director of Digital health at Brain Power, a neuroscience-based company focused on the development of augmented reality and data-driven technologies for autism and behavioral health. He is also faculty at Massachusetts General Hospital and Harvard Medical School. Dr. Vahabzadeh has trained in psychiatry, child

psychiatry, and family medicine. He is an expert on the application of wearable, immersive, and digital therapeutics for brain disorders. He has over 20 national and international awards in medical research, leadership, and innovation, and was the youngest Council Chairman at the American Psychiatric Association. He is a 40 under 40 healthcare innovator, and has been described as one of the future leaders in psychiatry. Dr. Vahabzadeh has numerous publications in authoritative texts, and has been quoted or written for many media outlets including CNN, USAToday, Huffington Post, Boston Globe, and Nature. He is also the Innovation Officer at the Massachusetts General Hospital Psychiatry Academy, the largest educational and consulting service for mental health in nation. He is a senior mentor for Neurolaunch, the world's first neuroscience startup accelerator.

Get Social Bring today’s important

conversation online via social

media. Tweet with #BHLSTS

about today’s symposium, new

insights, diversity in clinical

trials, diversity in the

workplace, healthcare

disparities, or any other

pressing D&I topics.

#BHLSTS

Planning

Committee Mr. Joseph Gaspero (Co-Chair) CEO, Center for Healthcare Innovation

Mr. Julius Pryor III (Co-Chair) Board of Directors, Center for Healthcare Innovation

Dr. Owen Garrick, MD, MBA President & COO, Bridge Clinical Research

Dr. James Gillespie, PhD, JD, MPA (Project Lead) President, Center for Healthcare Innovation

Ms. Regina Greer-Smith, MPH Member Advisory Panel on Patient Engagement,

Patient Centered Outcomes Research Institute (PCORI)

Ms. Virginia Solís Management Associate, Innovation, Diversity & Inclusion

Genentech

Ms. Regina Yabut Diversity Specialist

Genentech

Dr. Chad Womack, PhD National Director, STEM Initiatives and the Fund II

Foundation UNCF STEM Scholars Program

Sponsored By

CHI LEADERSHIP

CHI is a 501(c)(3) non-profit, charitable organization, and all donations are tax-exempt. Federal Tax ID # 27-3041119.

BOARD OF DIRECTORS Mr. Michel Feldman (Chairman), JD, Retired Partner, Seyfarth Shaw Dr. Cheryl Beal Anderson, PharmD, MBA, Vice-President, Head of Regulatory Affairs, Upsher-Smith Dr. Benée Brown, PharmD, Senior Medical Science Liaison, Sanofi Dr. James Gillespie, PhD, JD, MPA, Chief Executive Officer, Center for Healthcare Innovation Ms. Lynn Hanessian, Chief Science Strategist, Edelman Mr. Joff Masukawa, President, Diligentia Mr. Stephen Morales, MBA, Consultant, LEK Consulting Mr. Julius Pryor III, Author and Expert in Innovation, Diversity & Inclusion Dr. Linda Scarazzini, RPh, MD, Vice President, Pharmacovigilance & Patient Safety, AbbVie Mr. Douglas Swill, JD, LLM, Partner & Chair of Health Care Practice Group, Drinker Biddle & Reath

EXECUTIVE COUNCIL Mr. Dennis Urbaniak (Chairman), Managing Director, Accenture Mr. Mitchell DeKoven, MHSA, Principal, Health Economics and Outcomes Research, IMS Health Mr. Rick Goddard, MS, Director of Clinical Innovation, Advocate Health Care Dr. Albert Jaramillo, Managing Partner, Workplace International Ms. Bhavini Shah, MBA, Customer Success Director of Healthcare & Life Sciences, Salesforce Dr. Eckhard von Keutz, Senior Vice President, Head Global Early Development, Bayer Healthcare

RESEARCH GROUP Mr. James Jordan (Chairman), Distinguished Service Professor in Healthcare & Biotechnology

Management, Carnegie Mellon University Mr. Mark Kwatia (Vice Chairman), Cost Strategy, Abbott Laboratories Dr. G. Randall Green, Program Director, Cardiac Surgery, St. Joseph ’s Hospital Health Center Dr. Marco Quarta, Director, Inst. for Bioengineering in Stem Cell & Regenerative Medicine, Stanford Dr. Kate Rosenbluth, Chief Executive Officer, Cala Health Dr. James Su, Chief Science Officer, Lap IQ

MANAGEMENT TEAM Mr. Joseph Gaspero, CEO & Co-Founder, CHI Mr. Tolga Babur, Research Associate, CHI; MHA Student, Johns Hopkins Mr. Eugene Dinescu, Ambassador, CHI; Founder and Advisor, World Biotechnology Mr. Ryan Haake, MS, Research Associate, CHI; Molecular Biologist, Argonne National Laboratory Ms. Ritu Kamal, Ambassador, CHI; Global Project Manager, Biodesign Program, Stanford University Mr. Joshua Limp, Senior Project Manager, CHI Dr. Tina Shah, Ambassador, CHI; White House Fellow, U.S. Department. of Veteran Affairs Ms. Sandra Mumanachit, Ambassador, CHI; Senior Consultant, CVS health